Studies how people's bodies respond to different meals and foods
Tests how adults respond to mixed meals and everyday foods, including diabetes and heart disease.
Plain-language title generated from the registry record
Registry title: Personalized Responses to Dietary Composition Trial 3
Key facts
- Where
- London, United KingdomSee the site
Where in United Kingdom
- King's College LondonLondon, United KingdomTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Zoe Global Limited
- Trial code
- NCT04735835
- Record updated
- 16 April 2025
- Original description
The PREDICT 3 study will build on previous research in over 2,000 individuals to further refine machine learning models that predict individual responses to foods, with the aim of advancing precision nutrition science and individualized dietary advice. The study incorporates both standardized and controlled dietary intervention, for the purpose of testing postprandial responses to specific mixed meals, in addition to a free-living period with a dietary record for measuring responses to a large variety of meals consumed in a realistic context, where the role of external factors (e.g. exercise, sleep, time of day) on postprandial responses may be determined. For the first time this PREDICT study is built on top of a commercial product which will allow access to a much larger group of participants who are already collecting large amounts of data through digital and biochemical devices that can contribute to science.Read full original descriptionShow less
Personalized Responses to Dietary Composition Trial 3
The PREDICT 3 study will build on previous research in over 2,000 individuals to further refine machine learning models that predict individual responses to foods, with the aim of advancing precision nutrition science and individualized dietary advice. The study incorporates both standardized and controlled dietary intervention, for the purpose of testing postprandial responses to specific mixed meals, in addition to a free-living period with a dietary record for measuring responses to a large variety of meals consumed in a realistic context, where the role of external factors (e.g. exercise, sleep, time of day) on postprandial responses may be determined. For the first time this PREDICT study is built on top of a commercial product which will allow access to a much larger group of participants who are already collecting large amounts of data through digital and biochemical devices that can contribute to science.
Inclusion: Enrolled in the commercial ZOE testing program; Any sex; Minimum 18 years of age (minimum 19 years of age in Alabama and Nebraska due to state laws); Body mass index (BMI) of greater than or equal to 16.5 kg/m2; Living in the continental US states, other than in New York (excluded from the ZOE testing product also as they are unable to access the dried blood spot service provided by Quest), or living in the UK; Able and willing to comply with the study protocol and provide informed consent; Under care for chronic medical conditions (including eating disorders, type 1 diabetes, type 2 diabetes), and confirm they have checked with their primary care physician that this study is safe for them (US cohort only).
Exclusion: Cannot safely eat the pre-made test meals which contain standard US ingredients, e.g. due to allergy or recent gastrointestinal surgery, or are unwilling to consume these foods; Have had a heart attack (myocardial infarction), stroke/transient ischemic attack (TIA), or major surgery in the last two months; Are pregnant; Are unable to read and write in English, as the ZOE app is only available in English.